crucial legal arguments / Carlsberg hearing/ time limit
Dear all
the Carlsberg hearing on 8 of June poses some challenges. According to the EPO we might win on technical reasons, however, due to G3/19, the new Rule 28(2) will not be applied.
to allow us to introduce our legal grounds, we have to argue why Rule 28(2) should be applied on this patent.
End of next week I will send a letter to the EPO with some technicalities to be sorted out (translation etc) and also new legal analysis on G3/19 and EU Directive 98/44 (also using some existing text elements). Maybe this is not perfect, but it opens up the door for further discussions and interventions. By writing it, I had the impression that our arguments are even quite valid.
so please come back to me with your comments till Wednesday next week. Meanwhile I will start the editing process, sow e can be ready at end of next (as requested by EPO on telephone in a call yesterday).
I also will send an 'heads up mail' to the other oponents.
cheers
Christoph
Dear all,
I found this interesting article, sorry if you already received it... :
"*Derailing EU rules on new GMOs*
CRISPR-Files expose lobbying tactics to deregulate new GMOs"
29.03.2021 https://corporateeurope.org/en/2021/03/derailing-eu-rules-new-gmos https://corporateeurope.org/en/2021/03/derailing-eu-rules-new-gmos
*Executive summary*
The biotech industry is waging an ongoing battle to get its new generation of genetic modification techniques excluded from European GMO regulations. This would mean that plants, animals and micro-organisms, made using ‘genome editing’ techniques like CRISPR-Cas, would not be subject to safety checks, monitoring or consumer labelling. Corporate Europe Observatory has uncovered various new tactics used by the biotech industry to prepare the ground for such deregulation. Officials from national ministries were hand-picked for joint strategy meetings with lobbyists; a think-tank set up a new Taskforce with a large grant from the Gates Foundation to pave the way to GM deregulation via "climate narratives"; and a lobby platform built around a sign-on letter overstating its backing by research institutes. The European Commission is due to publish a study by the end of April about the new techniques which will provide a basis for further discussion among Member States. Civil society and farming groups call on the EU to prioritise environmental and health concerns, and keep GM safety checks in place.
participants (2)
-
Anne-Charlotte Moy -
Christoph Then